In a study published last week in The New England Journal of Medicine, British drugmaker AstraZeneca said that in a late-stage trial, its drug Lynparza reduced the risk of relapse and death in breast cancer patients with certain gene mutations.
Lynparza was developed with Merck, and works to inhibit PARP, a protein that repairs DNA damage to cells — including those that are cancerous. It can be given as a maintenance therapy or an active treatment after chemotherapy. The study found that compared to a placebo, Lynparza reduced the combined risk of recurrence of breast cancer or death from any cause by 42 percent, Reuters reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Why more and more adults are reaching for soft toysUnder The Radar Does the popularity of the Squishmallow show Gen Z are 'scared to grow up'?
-
Magazine solutions - December 27, 2024 / January 3, 2025Puzzles and Quizzes Issue - December 27, 2024 / January 3, 2025
-
Magazine printables - December 27, 2024 / January 3, 2025Puzzles and Quizzes Issue - December 27, 2024 / January 3, 2025
-
US won its war on 'murder hornets,' officials saySpeed Read The announcement comes five years after the hornets were first spotted in the US
-
Dark energy data suggest Einstein was rightSpeed Read Albert Einstein's 1915 theory of general relativity has been proven correct, according to data collected by the Dark Energy Spectroscopic Instrument
-
New DNA tests of Pompeii dead upend popular storiesSpeed Read An analysis of skeletal remains reveals that some Mount Vesuvius victims have been wrongly identified
-
NASA's Europa Clipper blasts off, seeking an oceanSpeed Read The ship is headed toward Jupiter on a yearslong journey
-
Detailed map of fly's brain holds clues to human mindSpeed Read This remarkable fruit fly brain analysis will aid in future human brain research
-
Finger-prickin' good: Are simpler blood tests seeing new life years after Theranos' demise?Today's Big Question One Texas company is working to bring these tests back into the mainstream
-
Universal donor blood is 'close' to realityUnder the Radar Scientists identify 'cocktail' of enzymes that destroy harmful antigens
-
Blind people will listen to next week's total eclipseSpeed Read While they can't see the event, they can hear it with a device that translates the sky's brightness into music
